TITLE

Lipid Anti-Lipid Antibody Responses Correlate with Disease Activity in Systemic Lupus Erythematosus

AUTHOR(S)
Jovanović, Vojislav; Abdul Aziz, Nurhuda; Lim, Yan Ting; Ng Ai Poh, Amanda; Jin Hui Chan, Sherlynn; Ho Xin Pei, Eliza; Lew, Fei Chuin; Shui, Guanghou; Jenner, Andrew M.; Bowen, Li; McKinney, Eoin F.; Lyons, Paul A.; Kemeny, Michael D.; Smith, Kenneth G. C.; Wenk, Markus R.; MacAry, Paul A.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder characterized by broad clinical manifestations including cardiovascular and renal complications with periodic disease flares and significant morbidity and mortality. One of the main contributing factors to the pathology of SLE is the accumulation and impaired clearance of immune complexes of which the principle components are host auto-antigens and antibodies. The contribution of host lipids to the formation of these autoimmune complexes remains poorly defined. The aim of the present study was to identify and analyze candidate lipid autoantigens and their corresponding anti–lipid antibody responses in a well-defined SLE patient cohort using a combination of immunological and biophysical techniques. Disease monitoring in the SLE cohort was undertaken with serial British Isles Lupus Assessment Group (BILAG) scoring. Correlations between specific lipid/anti-lipid responses were investigated as disease activity developed from active flares to quiescent during a follow up period. We report a significant negative correlation between anti-lipid antibodies for 24S-hydroxycholesterol, cardiolipin and phosphatidylserine with SLE disease activity. Taken together, these data suggest that lipid autoantigens represent a new family of biomarkers that can be employed to monitor disease activity plus the efficacy of therapeutic intervention in SLE.
ACCESSION #
87623890

 

Related Articles

  • Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Efthimiou, Petros; Blanco, Michelle // Modern Rheumatology (Springer Science & Business Media B.V.);Oct2009, Vol. 19 Issue 5, p457 

    Systemic lupus erythematosus is a chronic, multisystemic, autoimmune disease that may involve the central, peripheral, and autonomic nervous systems and can present with a wide variety of neurological and psychiatric manifestations. In this article, we review the recent literature pertaining to...

  • Clinical and serological correlates of antinucleosome antibodies in South Africans with systemic lupus erythematosus. Tikly, M.; Gould, T.; Wadee, A.; Westhuizen, E.; Mokgethwa, B. // Clinical Rheumatology;Dec2007, Vol. 26 Issue 12, p2121 

    Antinucleosome antibodies (AnuA) are increasingly recognized as an important biomarker in the diagnosis and subset stratification of patients with systemic lupus erythematosus (SLE). The aim of the study was to determine the sensitivity, specificity, and clinico-serological correlates of AnuA in...

  • A multi-marker approach to diagnosing autoimmune diseases. Schulte-Pelkum, Johannes; Schulz-Knappe, Peter // MLO: Medical Laboratory Observer;Oct2015, Vol. 47 Issue 10, p44 

    The article presents information on a multi-marker test for the diagnosis of autoimmune diseases like rheumatoid arthritis (RA), systemic sclerosis (SSc), and systemic lupus erythematosus (SLE). Topics include the lack of specificity of in vitro diagnostics (IVD), rheumatoid factor (RF)...

  • Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Brentjens, Jan R.; Sepulveda, Marian; Baliah, Ted; Bentzel, Carl; Erlanger, Bernard F.; Elwood, Charles; Months, Mario; Hsu, Konrad C.; Andres, Giuseppe A. // Kidney International;Jan1975, Vol. 7 Issue 1, p342 

    Renal tissues from 45 patients with SLE nephritis, 34 patients with idiopathic membranous nephropathy (IMN) and 77 patients with minimal glomerular disease (MGD) were studied by light, immunofluorescence and electron microscopy. Interstitial nephritis characterized by focal or diffuse...

  • New ELISA Kits using C3 Binding Glycoprotein from Cuscuta europea Detect Mainly IgM CIC in Rheumatoid Arthritis and Progressive Systemic Sclerosis, but not in Systemic Lupus Erythematosus. Stanilova, Spaska Angelova; Slavov, Emil Slavov // Clinical & Developmental Immunology;Jun-Dec2003, Vol. 10 Issue 2-4, p111 

    Elevated levels of circulating immune complexes (CIC), containing IgG, IgM or IgA antibodies were detected in the sera of patients with autoimmune diseases. This might indicate a different biological meaning of the three isotypes of immunoglobulin (Ig) in the CIC. Each CIC assay detected only...

  • High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus. Shimizu, Chie; Fujita, Takayuki; Fuke, Yoshinobu; Ito, Ken; Satomura, Atsushi; Matsumoto, Koichi; Soma, Masayoshi // Modern Rheumatology (Springer Science & Business Media B.V.);Feb2012, Vol. 22 Issue 1, p73 

    In systemic lupus erythematosus (SLE), glomerular involvement often progresses with the activity of the disease. Immune complexes and abnormal secretion of cytokines are thought to be involved in the central mechanism of the development of lupus nephritis. We investigated serum levels of...

  • Antibodies to DNA: infection or genetics? Pisetsky, D. S.; Vrabie, I. A. // Lupus;Nov2009, Vol. 18 Issue 13, p1176 

    Antibodies to DNA (anti-DNA) are the serological hallmark of systemic lupus erythematosus (SLE) and unique markers of the immunological disturbances critical to disease pathogenesis. In the form of immune complexes, anti-DNA autoantibodies can deposit in the tissue to incite inflammation and...

  • Therapeutic potential (1). Zack, Debra Jeske; Isenberg, David // Lupus;2008, Vol. 17 Issue 3, p259 

    The article focuses on the development of modern therapies for systemic lupus erythematosus (SLE) disease The study explores on the use of biomarkers in the drug developments for SLE. The study is designed to view the challenges faced by medical experts in developing potential drugs for SLE. The...

  • Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE. Skeoch, S; Haque, S; Pemberton, P; Bruce, IN // Lupus;Jul2014, Vol. 23 Issue 8, p819 

    The article compare levels of vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in systemic lupus erythematosus (SLE) patients. It determines association with clinical phenotype, disease activity and damage. 78 female SLE patients and 69 age-and sexmatched controls were included in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics